Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
Keiichi Enjyoji(Beth Israel Deaconess Hospital), Robert Rosenberg(Kantonsspital Baselland), Patricia D. Christie(Massachusetts Institute of Technology), Jan Schulte Am Esch(Beth Israel Deaconess Medical Center), Denisa D. Wagner(Boston Children's Hospital), Simon C. Robson(Beth Israel Deaconess Medical Center), Paul S. Frenette(Albert Einstein College of Medicine), Masato Imai(Beth Israel Deaconess Medical Center), David Beeler(Massachusetts Institute of Technology), Eva Csizmadia(Beth Israel Deaconess Medical Center), Miroslaw Lech(Massachusetts Institute of Technology), Jay M. Edelberg(Massachusetts Institute of Technology), Jean Sévigny(Université Laval), Yuan Lin(Beth Israel Deaconess Medical Center), Helen Rayburn(Lucile Packard Children's Hospital)
Cited by 575
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
|The Journal of Experimental Medicine|2011|827